nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—CYP2D6—Temsirolimus—kidney cancer	0.0599	0.0981	CbGbCtD
Almotriptan—CYP3A4—Everolimus—kidney cancer	0.0564	0.0923	CbGbCtD
Almotriptan—CYP2C8—Pazopanib—kidney cancer	0.0493	0.0808	CbGbCtD
Almotriptan—CYP1A2—Pazopanib—kidney cancer	0.0382	0.0625	CbGbCtD
Almotriptan—CYP3A4—Temsirolimus—kidney cancer	0.0381	0.0624	CbGbCtD
Almotriptan—CYP2C8—Erlotinib—kidney cancer	0.0352	0.0576	CbGbCtD
Almotriptan—CYP2C8—Paclitaxel—kidney cancer	0.0322	0.0528	CbGbCtD
Almotriptan—CYP2D6—Pazopanib—kidney cancer	0.0315	0.0515	CbGbCtD
Almotriptan—CYP2C8—Sorafenib—kidney cancer	0.0286	0.0469	CbGbCtD
Almotriptan—CYP1A2—Erlotinib—kidney cancer	0.0272	0.0446	CbGbCtD
Almotriptan—CYP2C19—Sorafenib—kidney cancer	0.024	0.0393	CbGbCtD
Almotriptan—CYP2D6—Erlotinib—kidney cancer	0.0224	0.0368	CbGbCtD
Almotriptan—CYP1A2—Sorafenib—kidney cancer	0.0222	0.0363	CbGbCtD
Almotriptan—CYP3A4—Pazopanib—kidney cancer	0.02	0.0328	CbGbCtD
Almotriptan—CYP2D6—Sorafenib—kidney cancer	0.0183	0.0299	CbGbCtD
Almotriptan—CYP2D6—Vinblastine—kidney cancer	0.018	0.0295	CbGbCtD
Almotriptan—CYP3A4—Erlotinib—kidney cancer	0.0143	0.0234	CbGbCtD
Almotriptan—CYP3A4—Paclitaxel—kidney cancer	0.0131	0.0214	CbGbCtD
Almotriptan—CYP3A4—Sorafenib—kidney cancer	0.0116	0.019	CbGbCtD
Almotriptan—CYP3A4—Vinblastine—kidney cancer	0.0115	0.0188	CbGbCtD
Almotriptan—CYP3A4—Vincristine—kidney cancer	0.0113	0.0185	CbGbCtD
Almotriptan—FMO3—urine—kidney cancer	0.0112	0.242	CbGeAlD
Almotriptan—CYP2D6—Doxorubicin—kidney cancer	0.0111	0.0181	CbGbCtD
Almotriptan—CYP3A4—Sunitinib—kidney cancer	0.0094	0.0154	CbGbCtD
Almotriptan—CYP3A4—Doxorubicin—kidney cancer	0.00704	0.0115	CbGbCtD
Almotriptan—CYP2C19—urine—kidney cancer	0.00495	0.107	CbGeAlD
Almotriptan—CYP1A2—urine—kidney cancer	0.00404	0.0872	CbGeAlD
Almotriptan—CYP2E1—urine—kidney cancer	0.00363	0.0784	CbGeAlD
Almotriptan—CYP3A4—urine—kidney cancer	0.00292	0.0631	CbGeAlD
Almotriptan—CYP2D6—urine—kidney cancer	0.00288	0.0621	CbGeAlD
Almotriptan—HTR1D—kidney—kidney cancer	0.0015	0.0325	CbGeAlD
Almotriptan—MAOA—nephron tubule—kidney cancer	0.0013	0.0281	CbGeAlD
Almotriptan—MAOA—renal system—kidney cancer	0.00118	0.0256	CbGeAlD
Almotriptan—MAOA—kidney—kidney cancer	0.00115	0.0247	CbGeAlD
Almotriptan—MAOA—cortex of kidney—kidney cancer	0.00112	0.0241	CbGeAlD
Almotriptan—MAOA—cardiac atrium—kidney cancer	0.00106	0.0229	CbGeAlD
Almotriptan—CYP2C8—renal system—kidney cancer	0.00106	0.0228	CbGeAlD
Almotriptan—CYP2C8—kidney—kidney cancer	0.00102	0.022	CbGeAlD
Almotriptan—CYP1A2—renal system—kidney cancer	0.000989	0.0213	CbGeAlD
Almotriptan—CYP2E1—nephron tubule—kidney cancer	0.000978	0.0211	CbGeAlD
Almotriptan—CYP2E1—renal system—kidney cancer	0.000889	0.0192	CbGeAlD
Almotriptan—CYP2E1—kidney—kidney cancer	0.00086	0.0185	CbGeAlD
Almotriptan—CYP2E1—cortex of kidney—kidney cancer	0.000837	0.0181	CbGeAlD
Almotriptan—Eletriptan—PTGS1—kidney cancer	0.000736	0.347	CrCbGaD
Almotriptan—CYP3A4—renal system—kidney cancer	0.000716	0.0154	CbGeAlD
Almotriptan—CYP2D6—renal system—kidney cancer	0.000704	0.0152	CbGeAlD
Almotriptan—CYP3A4—kidney—kidney cancer	0.000692	0.0149	CbGeAlD
Almotriptan—CYP2D6—kidney—kidney cancer	0.000681	0.0147	CbGeAlD
Almotriptan—Melatonin—CYP1A1—kidney cancer	0.000584	0.275	CrCbGaD
Almotriptan—Sumatriptan—ABCB1—kidney cancer	0.000442	0.209	CrCbGaD
Almotriptan—Eletriptan—ABCB1—kidney cancer	0.000358	0.169	CrCbGaD
Almotriptan—Ill-defined disorder—Paclitaxel—kidney cancer	0.000233	0.000865	CcSEcCtD
Almotriptan—Vomiting—Everolimus—kidney cancer	0.000233	0.000862	CcSEcCtD
Almotriptan—Paraesthesia—Vincristine—kidney cancer	0.000232	0.00086	CcSEcCtD
Almotriptan—Agitation—Paclitaxel—kidney cancer	0.000231	0.000856	CcSEcCtD
Almotriptan—Rash—Everolimus—kidney cancer	0.000231	0.000855	CcSEcCtD
Almotriptan—Dermatitis—Everolimus—kidney cancer	0.000231	0.000854	CcSEcCtD
Almotriptan—Headache—Vinblastine—kidney cancer	0.00023	0.000852	CcSEcCtD
Almotriptan—Angioedema—Paclitaxel—kidney cancer	0.00023	0.000851	CcSEcCtD
Almotriptan—Headache—Everolimus—kidney cancer	0.000229	0.000849	CcSEcCtD
Almotriptan—Body temperature increased—Dactinomycin—kidney cancer	0.000229	0.000847	CcSEcCtD
Almotriptan—Abdominal pain—Dactinomycin—kidney cancer	0.000229	0.000847	CcSEcCtD
Almotriptan—Visual impairment—Capecitabine—kidney cancer	0.000229	0.000847	CcSEcCtD
Almotriptan—Asthenia—Sorafenib—kidney cancer	0.000228	0.000844	CcSEcCtD
Almotriptan—Malaise—Paclitaxel—kidney cancer	0.000227	0.00084	CcSEcCtD
Almotriptan—Vertigo—Paclitaxel—kidney cancer	0.000226	0.000837	CcSEcCtD
Almotriptan—Syncope—Paclitaxel—kidney cancer	0.000226	0.000836	CcSEcCtD
Almotriptan—Hypersensitivity—Sunitinib—kidney cancer	0.000225	0.000834	CcSEcCtD
Almotriptan—Pruritus—Sorafenib—kidney cancer	0.000225	0.000832	CcSEcCtD
Almotriptan—Vomiting—Erlotinib—kidney cancer	0.000225	0.000831	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000223	0.000828	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Vincristine—kidney cancer	0.000223	0.000827	CcSEcCtD
Almotriptan—Fatigue—Vincristine—kidney cancer	0.000223	0.000826	CcSEcCtD
Almotriptan—Rash—Erlotinib—kidney cancer	0.000223	0.000825	CcSEcCtD
Almotriptan—Dermatitis—Erlotinib—kidney cancer	0.000222	0.000824	CcSEcCtD
Almotriptan—Palpitations—Paclitaxel—kidney cancer	0.000222	0.000823	CcSEcCtD
Almotriptan—Insomnia—Gemcitabine—kidney cancer	0.000222	0.000822	CcSEcCtD
Almotriptan—Eye disorder—Capecitabine—kidney cancer	0.000222	0.000821	CcSEcCtD
Almotriptan—Headache—Erlotinib—kidney cancer	0.000221	0.000819	CcSEcCtD
Almotriptan—Tinnitus—Capecitabine—kidney cancer	0.000221	0.000819	CcSEcCtD
Almotriptan—Loss of consciousness—Paclitaxel—kidney cancer	0.000221	0.000819	CcSEcCtD
Almotriptan—Pain—Vincristine—kidney cancer	0.000221	0.000819	CcSEcCtD
Almotriptan—Pain in extremity—Doxorubicin—kidney cancer	0.000221	0.000819	CcSEcCtD
Almotriptan—Diplopia—Doxorubicin—kidney cancer	0.000221	0.000819	CcSEcCtD
Almotriptan—Paraesthesia—Gemcitabine—kidney cancer	0.00022	0.000816	CcSEcCtD
Almotriptan—Cardiac disorder—Capecitabine—kidney cancer	0.00022	0.000815	CcSEcCtD
Almotriptan—Asthenia—Sunitinib—kidney cancer	0.000219	0.000812	CcSEcCtD
Almotriptan—Dyspnoea—Gemcitabine—kidney cancer	0.000219	0.00081	CcSEcCtD
Almotriptan—Nausea—Vinblastine—kidney cancer	0.000218	0.000808	CcSEcCtD
Almotriptan—Somnolence—Gemcitabine—kidney cancer	0.000218	0.000808	CcSEcCtD
Almotriptan—Convulsion—Paclitaxel—kidney cancer	0.000218	0.000807	CcSEcCtD
Almotriptan—Nausea—Everolimus—kidney cancer	0.000217	0.000805	CcSEcCtD
Almotriptan—Diarrhoea—Sorafenib—kidney cancer	0.000217	0.000805	CcSEcCtD
Almotriptan—Hypertension—Paclitaxel—kidney cancer	0.000217	0.000805	CcSEcCtD
Almotriptan—Pruritus—Sunitinib—kidney cancer	0.000216	0.000801	CcSEcCtD
Almotriptan—Immune system disorder—Capecitabine—kidney cancer	0.000214	0.000793	CcSEcCtD
Almotriptan—Myalgia—Paclitaxel—kidney cancer	0.000214	0.000793	CcSEcCtD
Almotriptan—Chest pain—Paclitaxel—kidney cancer	0.000214	0.000793	CcSEcCtD
Almotriptan—Arthralgia—Paclitaxel—kidney cancer	0.000214	0.000793	CcSEcCtD
Almotriptan—Anxiety—Paclitaxel—kidney cancer	0.000213	0.000791	CcSEcCtD
Almotriptan—Hypersensitivity—Dactinomycin—kidney cancer	0.000213	0.00079	CcSEcCtD
Almotriptan—Chills—Capecitabine—kidney cancer	0.000213	0.000788	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000213	0.000788	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000212	0.000784	CcSEcCtD
Almotriptan—Discomfort—Paclitaxel—kidney cancer	0.000212	0.000784	CcSEcCtD
Almotriptan—Fatigue—Gemcitabine—kidney cancer	0.000211	0.000783	CcSEcCtD
Almotriptan—Gastrointestinal pain—Vincristine—kidney cancer	0.000211	0.000783	CcSEcCtD
Almotriptan—Dizziness—Sorafenib—kidney cancer	0.00021	0.000778	CcSEcCtD
Almotriptan—Pain—Gemcitabine—kidney cancer	0.00021	0.000777	CcSEcCtD
Almotriptan—Nausea—Erlotinib—kidney cancer	0.00021	0.000777	CcSEcCtD
Almotriptan—Dry mouth—Paclitaxel—kidney cancer	0.00021	0.000776	CcSEcCtD
Almotriptan—Diarrhoea—Sunitinib—kidney cancer	0.000209	0.000775	CcSEcCtD
Almotriptan—Mental disorder—Capecitabine—kidney cancer	0.000208	0.00077	CcSEcCtD
Almotriptan—Asthenia—Dactinomycin—kidney cancer	0.000208	0.000769	CcSEcCtD
Almotriptan—Confusional state—Paclitaxel—kidney cancer	0.000207	0.000767	CcSEcCtD
Almotriptan—Erythema—Capecitabine—kidney cancer	0.000206	0.000765	CcSEcCtD
Almotriptan—Anaphylactic shock—Paclitaxel—kidney cancer	0.000205	0.000761	CcSEcCtD
Almotriptan—Body temperature increased—Vincristine—kidney cancer	0.000204	0.000757	CcSEcCtD
Almotriptan—Abdominal pain—Vincristine—kidney cancer	0.000204	0.000757	CcSEcCtD
Almotriptan—Dysgeusia—Capecitabine—kidney cancer	0.000202	0.000749	CcSEcCtD
Almotriptan—Dizziness—Sunitinib—kidney cancer	0.000202	0.000749	CcSEcCtD
Almotriptan—Feeling abnormal—Gemcitabine—kidney cancer	0.000202	0.000749	CcSEcCtD
Almotriptan—Shock—Paclitaxel—kidney cancer	0.000202	0.000748	CcSEcCtD
Almotriptan—Vomiting—Sorafenib—kidney cancer	0.000202	0.000748	CcSEcCtD
Almotriptan—Abdominal pain upper—Doxorubicin—kidney cancer	0.000202	0.000748	CcSEcCtD
Almotriptan—Nervous system disorder—Paclitaxel—kidney cancer	0.000201	0.000746	CcSEcCtD
Almotriptan—Tachycardia—Paclitaxel—kidney cancer	0.0002	0.000742	CcSEcCtD
Almotriptan—Rash—Sorafenib—kidney cancer	0.0002	0.000742	CcSEcCtD
Almotriptan—Dermatitis—Sorafenib—kidney cancer	0.0002	0.000741	CcSEcCtD
Almotriptan—Back pain—Capecitabine—kidney cancer	0.0002	0.00074	CcSEcCtD
Almotriptan—Breast disorder—Doxorubicin—kidney cancer	0.0002	0.00074	CcSEcCtD
Almotriptan—Skin disorder—Paclitaxel—kidney cancer	0.000199	0.000739	CcSEcCtD
Almotriptan—Headache—Sorafenib—kidney cancer	0.000199	0.000737	CcSEcCtD
Almotriptan—Hyperhidrosis—Paclitaxel—kidney cancer	0.000199	0.000735	CcSEcCtD
Almotriptan—Diarrhoea—Dactinomycin—kidney cancer	0.000198	0.000733	CcSEcCtD
Almotriptan—Gastritis—Doxorubicin—kidney cancer	0.000196	0.000724	CcSEcCtD
Almotriptan—Muscular weakness—Doxorubicin—kidney cancer	0.000195	0.000722	CcSEcCtD
Almotriptan—Vision blurred—Capecitabine—kidney cancer	0.000195	0.000721	CcSEcCtD
Almotriptan—Vomiting—Sunitinib—kidney cancer	0.000194	0.00072	CcSEcCtD
Almotriptan—Body temperature increased—Gemcitabine—kidney cancer	0.000194	0.000718	CcSEcCtD
Almotriptan—Tremor—Capecitabine—kidney cancer	0.000193	0.000716	CcSEcCtD
Almotriptan—Rash—Sunitinib—kidney cancer	0.000193	0.000714	CcSEcCtD
Almotriptan—Dermatitis—Sunitinib—kidney cancer	0.000193	0.000713	CcSEcCtD
Almotriptan—Ill-defined disorder—Capecitabine—kidney cancer	0.000192	0.00071	CcSEcCtD
Almotriptan—Headache—Sunitinib—kidney cancer	0.000191	0.000709	CcSEcCtD
Almotriptan—Hypersensitivity—Vincristine—kidney cancer	0.00019	0.000705	CcSEcCtD
Almotriptan—Nausea—Sorafenib—kidney cancer	0.000189	0.000699	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000187	0.000693	CcSEcCtD
Almotriptan—Malaise—Capecitabine—kidney cancer	0.000186	0.00069	CcSEcCtD
Almotriptan—Angina pectoris—Doxorubicin—kidney cancer	0.000186	0.000689	CcSEcCtD
Almotriptan—Insomnia—Paclitaxel—kidney cancer	0.000186	0.000688	CcSEcCtD
Almotriptan—Vertigo—Capecitabine—kidney cancer	0.000186	0.000687	CcSEcCtD
Almotriptan—Asthenia—Vincristine—kidney cancer	0.000186	0.000687	CcSEcCtD
Almotriptan—Syncope—Capecitabine—kidney cancer	0.000185	0.000686	CcSEcCtD
Almotriptan—Paraesthesia—Paclitaxel—kidney cancer	0.000184	0.000683	CcSEcCtD
Almotriptan—Vomiting—Dactinomycin—kidney cancer	0.000184	0.000681	CcSEcCtD
Almotriptan—Bronchitis—Doxorubicin—kidney cancer	0.000184	0.00068	CcSEcCtD
Almotriptan—Dyspnoea—Paclitaxel—kidney cancer	0.000183	0.000678	CcSEcCtD
Almotriptan—Somnolence—Paclitaxel—kidney cancer	0.000183	0.000676	CcSEcCtD
Almotriptan—Palpitations—Capecitabine—kidney cancer	0.000182	0.000676	CcSEcCtD
Almotriptan—Rash—Dactinomycin—kidney cancer	0.000182	0.000676	CcSEcCtD
Almotriptan—Nausea—Sunitinib—kidney cancer	0.000182	0.000672	CcSEcCtD
Almotriptan—Loss of consciousness—Capecitabine—kidney cancer	0.000181	0.000672	CcSEcCtD
Almotriptan—Dyspepsia—Paclitaxel—kidney cancer	0.000181	0.000669	CcSEcCtD
Almotriptan—Hypertension—Capecitabine—kidney cancer	0.000178	0.00066	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000177	0.000657	CcSEcCtD
Almotriptan—Fatigue—Paclitaxel—kidney cancer	0.000177	0.000656	CcSEcCtD
Almotriptan—Diarrhoea—Vincristine—kidney cancer	0.000177	0.000655	CcSEcCtD
Almotriptan—Asthenia—Gemcitabine—kidney cancer	0.000176	0.000652	CcSEcCtD
Almotriptan—Chest pain—Capecitabine—kidney cancer	0.000176	0.000651	CcSEcCtD
Almotriptan—Myalgia—Capecitabine—kidney cancer	0.000176	0.000651	CcSEcCtD
Almotriptan—Arthralgia—Capecitabine—kidney cancer	0.000176	0.000651	CcSEcCtD
Almotriptan—Pain—Paclitaxel—kidney cancer	0.000176	0.00065	CcSEcCtD
Almotriptan—Anxiety—Capecitabine—kidney cancer	0.000175	0.000649	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000175	0.000647	CcSEcCtD
Almotriptan—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000174	0.000646	CcSEcCtD
Almotriptan—Discomfort—Capecitabine—kidney cancer	0.000174	0.000643	CcSEcCtD
Almotriptan—Pruritus—Gemcitabine—kidney cancer	0.000174	0.000643	CcSEcCtD
Almotriptan—Hyperglycaemia—Doxorubicin—kidney cancer	0.000172	0.000638	CcSEcCtD
Almotriptan—Dry mouth—Capecitabine—kidney cancer	0.000172	0.000637	CcSEcCtD
Almotriptan—Nausea—Dactinomycin—kidney cancer	0.000172	0.000637	CcSEcCtD
Almotriptan—Dizziness—Vincristine—kidney cancer	0.000171	0.000633	CcSEcCtD
Almotriptan—Confusional state—Capecitabine—kidney cancer	0.00017	0.000629	CcSEcCtD
Almotriptan—Feeling abnormal—Paclitaxel—kidney cancer	0.000169	0.000627	CcSEcCtD
Almotriptan—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000168	0.000622	CcSEcCtD
Almotriptan—Diarrhoea—Gemcitabine—kidney cancer	0.000168	0.000621	CcSEcCtD
Almotriptan—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000167	0.000618	CcSEcCtD
Almotriptan—Shock—Capecitabine—kidney cancer	0.000166	0.000614	CcSEcCtD
Almotriptan—Conjunctivitis—Doxorubicin—kidney cancer	0.000166	0.000613	CcSEcCtD
Almotriptan—Nervous system disorder—Capecitabine—kidney cancer	0.000165	0.000612	CcSEcCtD
Almotriptan—Tachycardia—Capecitabine—kidney cancer	0.000164	0.000609	CcSEcCtD
Almotriptan—Vomiting—Vincristine—kidney cancer	0.000164	0.000609	CcSEcCtD
Almotriptan—Skin disorder—Capecitabine—kidney cancer	0.000164	0.000606	CcSEcCtD
Almotriptan—Rash—Vincristine—kidney cancer	0.000163	0.000604	CcSEcCtD
Almotriptan—Hyperhidrosis—Capecitabine—kidney cancer	0.000163	0.000603	CcSEcCtD
Almotriptan—Dermatitis—Vincristine—kidney cancer	0.000163	0.000603	CcSEcCtD
Almotriptan—Body temperature increased—Paclitaxel—kidney cancer	0.000162	0.000601	CcSEcCtD
Almotriptan—Abdominal pain—Paclitaxel—kidney cancer	0.000162	0.000601	CcSEcCtD
Almotriptan—Headache—Vincristine—kidney cancer	0.000162	0.0006	CcSEcCtD
Almotriptan—Epistaxis—Doxorubicin—kidney cancer	0.000161	0.000595	CcSEcCtD
Almotriptan—Sinusitis—Doxorubicin—kidney cancer	0.00016	0.000592	CcSEcCtD
Almotriptan—Vomiting—Gemcitabine—kidney cancer	0.000156	0.000578	CcSEcCtD
Almotriptan—Rash—Gemcitabine—kidney cancer	0.000155	0.000573	CcSEcCtD
Almotriptan—Dermatitis—Gemcitabine—kidney cancer	0.000155	0.000572	CcSEcCtD
Almotriptan—Headache—Gemcitabine—kidney cancer	0.000154	0.000569	CcSEcCtD
Almotriptan—Nausea—Vincristine—kidney cancer	0.000154	0.000569	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000154	0.000569	CcSEcCtD
Almotriptan—Rhinitis—Doxorubicin—kidney cancer	0.000153	0.000568	CcSEcCtD
Almotriptan—Insomnia—Capecitabine—kidney cancer	0.000152	0.000564	CcSEcCtD
Almotriptan—Hypoaesthesia—Doxorubicin—kidney cancer	0.000152	0.000563	CcSEcCtD
Almotriptan—Pharyngitis—Doxorubicin—kidney cancer	0.000152	0.000562	CcSEcCtD
Almotriptan—Paraesthesia—Capecitabine—kidney cancer	0.000151	0.00056	CcSEcCtD
Almotriptan—Hypersensitivity—Paclitaxel—kidney cancer	0.000151	0.00056	CcSEcCtD
Almotriptan—Dyspnoea—Capecitabine—kidney cancer	0.00015	0.000556	CcSEcCtD
Almotriptan—Dyspepsia—Capecitabine—kidney cancer	0.000148	0.000549	CcSEcCtD
Almotriptan—Visual impairment—Doxorubicin—kidney cancer	0.000147	0.000546	CcSEcCtD
Almotriptan—Asthenia—Paclitaxel—kidney cancer	0.000147	0.000546	CcSEcCtD
Almotriptan—Nausea—Gemcitabine—kidney cancer	0.000146	0.00054	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000145	0.000539	CcSEcCtD
Almotriptan—Fatigue—Capecitabine—kidney cancer	0.000145	0.000538	CcSEcCtD
Almotriptan—Pruritus—Paclitaxel—kidney cancer	0.000145	0.000538	CcSEcCtD
Almotriptan—Pain—Capecitabine—kidney cancer	0.000144	0.000534	CcSEcCtD
Almotriptan—Eye disorder—Doxorubicin—kidney cancer	0.000143	0.000529	CcSEcCtD
Almotriptan—Tinnitus—Doxorubicin—kidney cancer	0.000143	0.000528	CcSEcCtD
Almotriptan—Cardiac disorder—Doxorubicin—kidney cancer	0.000142	0.000526	CcSEcCtD
Almotriptan—Diarrhoea—Paclitaxel—kidney cancer	0.000141	0.00052	CcSEcCtD
Almotriptan—Feeling abnormal—Capecitabine—kidney cancer	0.000139	0.000514	CcSEcCtD
Almotriptan—Immune system disorder—Doxorubicin—kidney cancer	0.000138	0.000511	CcSEcCtD
Almotriptan—Gastrointestinal pain—Capecitabine—kidney cancer	0.000138	0.00051	CcSEcCtD
Almotriptan—Chills—Doxorubicin—kidney cancer	0.000137	0.000508	CcSEcCtD
Almotriptan—Dizziness—Paclitaxel—kidney cancer	0.000136	0.000503	CcSEcCtD
Almotriptan—Mental disorder—Doxorubicin—kidney cancer	0.000134	0.000496	CcSEcCtD
Almotriptan—Body temperature increased—Capecitabine—kidney cancer	0.000133	0.000493	CcSEcCtD
Almotriptan—Abdominal pain—Capecitabine—kidney cancer	0.000133	0.000493	CcSEcCtD
Almotriptan—Erythema—Doxorubicin—kidney cancer	0.000133	0.000493	CcSEcCtD
Almotriptan—Tension—Doxorubicin—kidney cancer	0.000131	0.000484	CcSEcCtD
Almotriptan—Vomiting—Paclitaxel—kidney cancer	0.000131	0.000484	CcSEcCtD
Almotriptan—Dysgeusia—Doxorubicin—kidney cancer	0.00013	0.000483	CcSEcCtD
Almotriptan—Rash—Paclitaxel—kidney cancer	0.000129	0.00048	CcSEcCtD
Almotriptan—Dermatitis—Paclitaxel—kidney cancer	0.000129	0.000479	CcSEcCtD
Almotriptan—Nervousness—Doxorubicin—kidney cancer	0.000129	0.000479	CcSEcCtD
Almotriptan—Back pain—Doxorubicin—kidney cancer	0.000129	0.000477	CcSEcCtD
Almotriptan—Headache—Paclitaxel—kidney cancer	0.000129	0.000476	CcSEcCtD
Almotriptan—Vision blurred—Doxorubicin—kidney cancer	0.000125	0.000465	CcSEcCtD
Almotriptan—Hypersensitivity—Capecitabine—kidney cancer	0.000124	0.00046	CcSEcCtD
Almotriptan—Ill-defined disorder—Doxorubicin—kidney cancer	0.000123	0.000457	CcSEcCtD
Almotriptan—Agitation—Doxorubicin—kidney cancer	0.000122	0.000453	CcSEcCtD
Almotriptan—Nausea—Paclitaxel—kidney cancer	0.000122	0.000452	CcSEcCtD
Almotriptan—Asthenia—Capecitabine—kidney cancer	0.000121	0.000448	CcSEcCtD
Almotriptan—Malaise—Doxorubicin—kidney cancer	0.00012	0.000445	CcSEcCtD
Almotriptan—Vertigo—Doxorubicin—kidney cancer	0.00012	0.000443	CcSEcCtD
Almotriptan—Syncope—Doxorubicin—kidney cancer	0.000119	0.000442	CcSEcCtD
Almotriptan—Pruritus—Capecitabine—kidney cancer	0.000119	0.000442	CcSEcCtD
Almotriptan—Palpitations—Doxorubicin—kidney cancer	0.000118	0.000436	CcSEcCtD
Almotriptan—Loss of consciousness—Doxorubicin—kidney cancer	0.000117	0.000433	CcSEcCtD
Almotriptan—Convulsion—Doxorubicin—kidney cancer	0.000115	0.000427	CcSEcCtD
Almotriptan—Diarrhoea—Capecitabine—kidney cancer	0.000115	0.000427	CcSEcCtD
Almotriptan—Hypertension—Doxorubicin—kidney cancer	0.000115	0.000426	CcSEcCtD
Almotriptan—Chest pain—Doxorubicin—kidney cancer	0.000113	0.00042	CcSEcCtD
Almotriptan—Arthralgia—Doxorubicin—kidney cancer	0.000113	0.00042	CcSEcCtD
Almotriptan—Myalgia—Doxorubicin—kidney cancer	0.000113	0.00042	CcSEcCtD
Almotriptan—Anxiety—Doxorubicin—kidney cancer	0.000113	0.000418	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000113	0.000417	CcSEcCtD
Almotriptan—Discomfort—Doxorubicin—kidney cancer	0.000112	0.000415	CcSEcCtD
Almotriptan—Dizziness—Capecitabine—kidney cancer	0.000111	0.000413	CcSEcCtD
Almotriptan—Dry mouth—Doxorubicin—kidney cancer	0.000111	0.00041	CcSEcCtD
Almotriptan—Confusional state—Doxorubicin—kidney cancer	0.00011	0.000406	CcSEcCtD
Almotriptan—Anaphylactic shock—Doxorubicin—kidney cancer	0.000109	0.000402	CcSEcCtD
Almotriptan—Vomiting—Capecitabine—kidney cancer	0.000107	0.000397	CcSEcCtD
Almotriptan—Shock—Doxorubicin—kidney cancer	0.000107	0.000396	CcSEcCtD
Almotriptan—Nervous system disorder—Doxorubicin—kidney cancer	0.000107	0.000395	CcSEcCtD
Almotriptan—Rash—Capecitabine—kidney cancer	0.000106	0.000394	CcSEcCtD
Almotriptan—Dermatitis—Capecitabine—kidney cancer	0.000106	0.000393	CcSEcCtD
Almotriptan—Tachycardia—Doxorubicin—kidney cancer	0.000106	0.000393	CcSEcCtD
Almotriptan—Headache—Capecitabine—kidney cancer	0.000106	0.000391	CcSEcCtD
Almotriptan—Skin disorder—Doxorubicin—kidney cancer	0.000106	0.000391	CcSEcCtD
Almotriptan—Hyperhidrosis—Doxorubicin—kidney cancer	0.000105	0.000389	CcSEcCtD
Almotriptan—Nausea—Capecitabine—kidney cancer	0.0001	0.000371	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Doxorubicin—kidney cancer	9.9e-05	0.000367	CcSEcCtD
Almotriptan—Insomnia—Doxorubicin—kidney cancer	9.83e-05	0.000364	CcSEcCtD
Almotriptan—Paraesthesia—Doxorubicin—kidney cancer	9.75e-05	0.000361	CcSEcCtD
Almotriptan—Dyspnoea—Doxorubicin—kidney cancer	9.68e-05	0.000359	CcSEcCtD
Almotriptan—Somnolence—Doxorubicin—kidney cancer	9.66e-05	0.000358	CcSEcCtD
Almotriptan—Dyspepsia—Doxorubicin—kidney cancer	9.56e-05	0.000354	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Doxorubicin—kidney cancer	9.38e-05	0.000347	CcSEcCtD
Almotriptan—Fatigue—Doxorubicin—kidney cancer	9.37e-05	0.000347	CcSEcCtD
Almotriptan—Pain—Doxorubicin—kidney cancer	9.29e-05	0.000344	CcSEcCtD
Almotriptan—Feeling abnormal—Doxorubicin—kidney cancer	8.95e-05	0.000332	CcSEcCtD
Almotriptan—Gastrointestinal pain—Doxorubicin—kidney cancer	8.88e-05	0.000329	CcSEcCtD
Almotriptan—Body temperature increased—Doxorubicin—kidney cancer	8.59e-05	0.000318	CcSEcCtD
Almotriptan—Abdominal pain—Doxorubicin—kidney cancer	8.59e-05	0.000318	CcSEcCtD
Almotriptan—Hypersensitivity—Doxorubicin—kidney cancer	8e-05	0.000296	CcSEcCtD
Almotriptan—Asthenia—Doxorubicin—kidney cancer	7.79e-05	0.000289	CcSEcCtD
Almotriptan—Pruritus—Doxorubicin—kidney cancer	7.69e-05	0.000285	CcSEcCtD
Almotriptan—Diarrhoea—Doxorubicin—kidney cancer	7.43e-05	0.000275	CcSEcCtD
Almotriptan—Dizziness—Doxorubicin—kidney cancer	7.18e-05	0.000266	CcSEcCtD
Almotriptan—Vomiting—Doxorubicin—kidney cancer	6.91e-05	0.000256	CcSEcCtD
Almotriptan—Rash—Doxorubicin—kidney cancer	6.85e-05	0.000254	CcSEcCtD
Almotriptan—Dermatitis—Doxorubicin—kidney cancer	6.84e-05	0.000253	CcSEcCtD
Almotriptan—Headache—Doxorubicin—kidney cancer	6.81e-05	0.000252	CcSEcCtD
Almotriptan—Nausea—Doxorubicin—kidney cancer	6.45e-05	0.000239	CcSEcCtD
Almotriptan—HTR1B—GPCR downstream signaling—POMC—kidney cancer	2.26e-05	0.000319	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ALAD—kidney cancer	2.24e-05	0.000316	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.24e-05	0.000316	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PGK1—kidney cancer	2.23e-05	0.000314	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—SLC5A3—kidney cancer	2.23e-05	0.000314	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—JUNB—kidney cancer	2.22e-05	0.000313	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PAK1—kidney cancer	2.22e-05	0.000313	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ST3GAL2—kidney cancer	2.19e-05	0.000309	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—LDHB—kidney cancer	2.18e-05	0.000308	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PDHB—kidney cancer	2.17e-05	0.000306	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—PTGS2—kidney cancer	2.17e-05	0.000306	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—POMC—kidney cancer	2.16e-05	0.000305	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ALDH1A1—kidney cancer	2.14e-05	0.000302	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—APRT—kidney cancer	2.13e-05	0.000301	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—FH—kidney cancer	2.13e-05	0.000301	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CA9—kidney cancer	2.12e-05	0.0003	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—POMC—kidney cancer	2.09e-05	0.000296	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CRABP1—kidney cancer	2.09e-05	0.000295	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.08e-05	0.000294	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.07e-05	0.000293	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—POMC—kidney cancer	2.05e-05	0.00029	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—SLC5A3—kidney cancer	2.05e-05	0.000289	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PGK1—kidney cancer	2.05e-05	0.000289	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CCBL1—kidney cancer	2.04e-05	0.000288	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—LDHB—kidney cancer	2.01e-05	0.000284	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GPC3—kidney cancer	2e-05	0.000283	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—GSTP1—kidney cancer	2e-05	0.000282	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CA2—kidney cancer	1.95e-05	0.000275	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ITPR2—kidney cancer	1.94e-05	0.000274	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ALAD—kidney cancer	1.9e-05	0.000268	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CA9—kidney cancer	1.89e-05	0.000267	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—ABCB1—kidney cancer	1.89e-05	0.000267	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—PTEN—kidney cancer	1.89e-05	0.000267	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IGF2—kidney cancer	1.85e-05	0.000262	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.85e-05	0.000261	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.85e-05	0.000261	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CDKN2B—kidney cancer	1.85e-05	0.000261	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—GSTM1—kidney cancer	1.84e-05	0.000259	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IGF2—kidney cancer	1.82e-05	0.000256	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.81e-05	0.000256	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CDKN2B—kidney cancer	1.81e-05	0.000255	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CRABP1—kidney cancer	1.8e-05	0.000255	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IGF1R—kidney cancer	1.79e-05	0.000253	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GSTT1—kidney cancer	1.77e-05	0.00025	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ACHE—kidney cancer	1.77e-05	0.00025	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PPAT—kidney cancer	1.77e-05	0.000249	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.77e-05	0.000249	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IGF1R—kidney cancer	1.76e-05	0.000248	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CA9—kidney cancer	1.74e-05	0.000246	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CYP1A1—kidney cancer	1.74e-05	0.000246	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PGK1—kidney cancer	1.74e-05	0.000245	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.74e-05	0.000245	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—RAF1—kidney cancer	1.73e-05	0.000244	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—IL2—kidney cancer	1.71e-05	0.000241	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—LDHB—kidney cancer	1.7e-05	0.00024	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—RAF1—kidney cancer	1.69e-05	0.000239	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ITPR2—kidney cancer	1.68e-05	0.000237	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—SCARB1—kidney cancer	1.68e-05	0.000236	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—IL2—kidney cancer	1.67e-05	0.000236	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PTGS1—kidney cancer	1.66e-05	0.000234	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—FH—kidney cancer	1.64e-05	0.000232	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—APRT—kidney cancer	1.64e-05	0.000232	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PSMD7—kidney cancer	1.63e-05	0.00023	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CRABP1—kidney cancer	1.61e-05	0.000227	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL2—kidney cancer	1.55e-05	0.000219	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.55e-05	0.000218	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GPC3—kidney cancer	1.54e-05	0.000218	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—BCHE—kidney cancer	1.54e-05	0.000218	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GSTT1—kidney cancer	1.53e-05	0.000216	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ACHE—kidney cancer	1.53e-05	0.000216	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—SLC5A5—kidney cancer	1.52e-05	0.000215	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL2—kidney cancer	1.52e-05	0.000214	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CA2—kidney cancer	1.5e-05	0.000212	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ITPR2—kidney cancer	1.5e-05	0.000211	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CRABP1—kidney cancer	1.48e-05	0.000209	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CA9—kidney cancer	1.48e-05	0.000208	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HIF1A—kidney cancer	1.48e-05	0.000208	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TSC2—kidney cancer	1.47e-05	0.000208	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—SLC2A1—kidney cancer	1.47e-05	0.000208	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALAD—kidney cancer	1.46e-05	0.000207	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—SCARB1—kidney cancer	1.45e-05	0.000204	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HIF1A—kidney cancer	1.44e-05	0.000204	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.44e-05	0.000204	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TSC2—kidney cancer	1.44e-05	0.000203	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PTGS1—kidney cancer	1.43e-05	0.000202	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.43e-05	0.000202	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—KDR—kidney cancer	1.41e-05	0.000199	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PSMD7—kidney cancer	1.41e-05	0.000198	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.4e-05	0.000197	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—KDR—kidney cancer	1.38e-05	0.000195	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.38e-05	0.000195	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ITPR2—kidney cancer	1.38e-05	0.000194	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ACHE—kidney cancer	1.37e-05	0.000193	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTT1—kidney cancer	1.37e-05	0.000193	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.34e-05	0.000189	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PGK1—kidney cancer	1.34e-05	0.000189	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—PIK3CA—kidney cancer	1.33e-05	0.000188	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—BCHE—kidney cancer	1.33e-05	0.000188	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—SLC5A5—kidney cancer	1.32e-05	0.000186	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—LDHB—kidney cancer	1.31e-05	0.000185	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—APC—kidney cancer	1.3e-05	0.000184	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—KIT—kidney cancer	1.3e-05	0.000184	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—POMC—kidney cancer	1.3e-05	0.000183	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—SCARB1—kidney cancer	1.29e-05	0.000182	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PTGS1—kidney cancer	1.28e-05	0.000181	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—KIT—kidney cancer	1.27e-05	0.00018	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—APC—kidney cancer	1.27e-05	0.00018	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—SLC2A1—kidney cancer	1.27e-05	0.000179	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTT1—kidney cancer	1.26e-05	0.000177	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ACHE—kidney cancer	1.26e-05	0.000177	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CRABP1—kidney cancer	1.25e-05	0.000177	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PSMD7—kidney cancer	1.25e-05	0.000177	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—MAPK3—kidney cancer	1.24e-05	0.000176	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—POMC—kidney cancer	1.24e-05	0.000175	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.23e-05	0.000174	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GSTP1—kidney cancer	1.23e-05	0.000173	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—BRAF—kidney cancer	1.22e-05	0.000172	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—MAPK3—kidney cancer	1.22e-05	0.000172	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—POMC—kidney cancer	1.21e-05	0.000171	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—BRAF—kidney cancer	1.2e-05	0.000169	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—BCHE—kidney cancer	1.19e-05	0.000168	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—SCARB1—kidney cancer	1.19e-05	0.000168	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—MAPK1—kidney cancer	1.18e-05	0.000167	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PTGS1—kidney cancer	1.18e-05	0.000166	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—SLC5A5—kidney cancer	1.17e-05	0.000166	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ITPR2—kidney cancer	1.17e-05	0.000165	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ABCB1—kidney cancer	1.16e-05	0.000164	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—MAPK1—kidney cancer	1.16e-05	0.000164	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PSMD7—kidney cancer	1.15e-05	0.000163	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CA9—kidney cancer	1.14e-05	0.000161	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—SLC2A1—kidney cancer	1.13e-05	0.00016	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—PIK3CA—kidney cancer	1.13e-05	0.00016	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GSTM1—kidney cancer	1.13e-05	0.000159	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—KRAS—kidney cancer	1.12e-05	0.000158	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—PIK3CA—kidney cancer	1.11e-05	0.000156	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.1e-05	0.000155	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—KRAS—kidney cancer	1.1e-05	0.000155	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—BCHE—kidney cancer	1.09e-05	0.000154	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.08e-05	0.000153	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.08e-05	0.000152	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.08e-05	0.000152	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP1A1—kidney cancer	1.07e-05	0.000151	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ACHE—kidney cancer	1.06e-05	0.00015	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTT1—kidney cancer	1.06e-05	0.00015	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GSTP1—kidney cancer	1.06e-05	0.00015	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.04e-05	0.000147	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PTGS2—kidney cancer	1.04e-05	0.000146	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—PIK3CA—kidney cancer	1.03e-05	0.000145	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—RAF1—kidney cancer	1.02e-05	0.000144	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—RELA—kidney cancer	1.02e-05	0.000143	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ERBB2—kidney cancer	1.01e-05	0.000142	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—SCARB1—kidney cancer	1.01e-05	0.000142	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—PIK3CA—kidney cancer	1.01e-05	0.000142	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ABCB1—kidney cancer	1e-05	0.000142	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—RAF1—kidney cancer	9.99e-06	0.000141	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PTGS1—kidney cancer	9.97e-06	0.000141	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MTOR—kidney cancer	9.96e-06	0.000141	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—RELA—kidney cancer	9.95e-06	0.00014	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ERBB2—kidney cancer	9.88e-06	0.00014	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PSMD7—kidney cancer	9.78e-06	0.000138	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MTOR—kidney cancer	9.75e-06	0.000138	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GSTM1—kidney cancer	9.74e-06	0.000138	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CRABP1—kidney cancer	9.68e-06	0.000137	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.6e-06	0.000136	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTP1—kidney cancer	9.46e-06	0.000134	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CDKN1B—kidney cancer	9.35e-06	0.000132	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—BCHE—kidney cancer	9.27e-06	0.000131	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP1A1—kidney cancer	9.24e-06	0.00013	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—SLC5A5—kidney cancer	9.15e-06	0.000129	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CDKN1B—kidney cancer	9.15e-06	0.000129	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL2—kidney cancer	9.15e-06	0.000129	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PTEN—kidney cancer	9.03e-06	0.000128	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ITPR2—kidney cancer	9e-06	0.000127	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ABCB1—kidney cancer	8.96e-06	0.000126	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL2—kidney cancer	8.96e-06	0.000126	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCND1—kidney cancer	8.92e-06	0.000126	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—JUN—kidney cancer	8.9e-06	0.000126	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—SLC2A1—kidney cancer	8.84e-06	0.000125	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CTNNB1—kidney cancer	8.83e-06	0.000125	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCND1—kidney cancer	8.73e-06	0.000123	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—JUN—kidney cancer	8.71e-06	0.000123	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTP1—kidney cancer	8.7e-06	0.000123	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTM1—kidney cancer	8.7e-06	0.000123	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CTNNB1—kidney cancer	8.65e-06	0.000122	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PTEN—kidney cancer	8.61e-06	0.000122	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.58e-06	0.000121	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PTEN—kidney cancer	8.43e-06	0.000119	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP1A1—kidney cancer	8.24e-06	0.000116	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ABCB1—kidney cancer	8.24e-06	0.000116	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ACHE—kidney cancer	8.21e-06	0.000116	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTT1—kidney cancer	8.21e-06	0.000116	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTM1—kidney cancer	8e-06	0.000113	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—POMC—kidney cancer	7.97e-06	0.000112	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—VEGFA—kidney cancer	7.77e-06	0.00011	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SCARB1—kidney cancer	7.77e-06	0.00011	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PTGS1—kidney cancer	7.69e-06	0.000109	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—VEGFA—kidney cancer	7.61e-06	0.000107	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.59e-06	0.000107	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP1A1—kidney cancer	7.58e-06	0.000107	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PSMD7—kidney cancer	7.54e-06	0.000106	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.48e-06	0.000106	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTP1—kidney cancer	7.37e-06	0.000104	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MAPK3—kidney cancer	7.35e-06	0.000104	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MAPK3—kidney cancer	7.2e-06	0.000102	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MYC—kidney cancer	7.15e-06	0.000101	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—BCHE—kidney cancer	7.15e-06	0.000101	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SLC5A5—kidney cancer	7.06e-06	9.97e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MYC—kidney cancer	7e-06	9.89e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MAPK1—kidney cancer	7e-06	9.88e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ABCB1—kidney cancer	6.98e-06	9.85e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—POMC—kidney cancer	6.89e-06	9.72e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MAPK1—kidney cancer	6.85e-06	9.67e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SLC2A1—kidney cancer	6.82e-06	9.63e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTM1—kidney cancer	6.78e-06	9.56e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.77e-06	9.56e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—KRAS—kidney cancer	6.61e-06	9.33e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—KRAS—kidney cancer	6.47e-06	9.14e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP1A1—kidney cancer	6.42e-06	9.07e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3CA—kidney cancer	6.37e-06	9e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PTGS2—kidney cancer	6.35e-06	8.97e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—POMC—kidney cancer	6.15e-06	8.68e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3CA—kidney cancer	6.07e-06	8.57e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3CA—kidney cancer	5.95e-06	8.39e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TP53—kidney cancer	5.87e-06	8.29e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TP53—kidney cancer	5.75e-06	8.12e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTP1—kidney cancer	5.69e-06	8.03e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—POMC—kidney cancer	5.65e-06	7.98e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PTEN—kidney cancer	5.54e-06	7.82e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PTGS2—kidney cancer	5.49e-06	7.75e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ABCB1—kidney cancer	5.39e-06	7.6e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.28e-06	7.45e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTM1—kidney cancer	5.23e-06	7.38e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP1A1—kidney cancer	4.96e-06	7e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PTGS2—kidney cancer	4.9e-06	6.92e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PTEN—kidney cancer	4.79e-06	6.76e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—POMC—kidney cancer	4.79e-06	6.76e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PTGS2—kidney cancer	4.51e-06	6.37e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PTEN—kidney cancer	4.28e-06	6.04e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PTEN—kidney cancer	3.93e-06	5.55e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CA—kidney cancer	3.91e-06	5.52e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PTGS2—kidney cancer	3.82e-06	5.39e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—POMC—kidney cancer	3.7e-06	5.22e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CA—kidney cancer	3.38e-06	4.77e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PTEN—kidney cancer	3.33e-06	4.7e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CA—kidney cancer	3.02e-06	4.26e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PTGS2—kidney cancer	2.95e-06	4.16e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CA—kidney cancer	2.77e-06	3.92e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PTEN—kidney cancer	2.57e-06	3.63e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CA—kidney cancer	2.35e-06	3.32e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.81e-06	2.56e-05	CbGpPWpGaD
